You are here

  • Home
  • Archive
  • Volume 81, Issue 7
  • Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome

Article info

Article menu
Sjögren’s syndrome
Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome

Authors

  • Raphaele Seror Paris-Saclay University, INSERM UMR1184: Centre for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicetre, France Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux universitaires Paris-Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Gabriel Baron Assistance Publique Hôpitaux de Paris, Hôtel Dieu hospital, Paris, France Centre d'Epidémiologie Clinique, INSERM U1153, Faculté de Médecine, Université Paris Descartes, Paris, France PubMed articlesGoogle scholar articles
  • Marine Camus Paris-Saclay University, INSERM UMR1184: Centre for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicetre, France Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux universitaires Paris-Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Divi Cornec Rhumatologie, CHU Brest, Brest, France Université de Brest, INSERM UMR 1227, LBAI, Brest, France PubMed articlesGoogle scholar articles
  • Elodie Perrodeau Assistance Publique Hôpitaux de Paris, Hôtel Dieu hospital, Paris, France Centre d'Epidémiologie Clinique, INSERM U1153, Faculté de Médecine, Université Paris Descartes, Paris, France PubMed articlesGoogle scholar articles
  • Simon J Bowman Rheumatology, University Hospitals Birmingham, Birmingham, UK Rheumatology, Milton Keynes University Hospital, Milton Keynes, UK University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Michele Bombardieri Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Hendrika Bootsma Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Jacques-Eric Gottenberg Rheumatology, University Hospital of Strasbourg, Strasbourg, France Université de Strasbourg, IBMC, CNRS, UPR3572, Strasbourg, France PubMed articlesGoogle scholar articles
  • Benjamin Fisher National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Wolfgang Hueber Novartis Pharma, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Joel A van Roon Immunology, Rheumatology and Clinical Immunology, Center of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Valérie Devauchelle-Pensec Rhumatologie, CHU Brest, Brest, France Université de Brest, INSERM UMR 1227, LBAI, Brest, France PubMed articlesGoogle scholar articles
  • Peter Gergely Novartis Institutes for BioMedical Research Basel, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Xavier Mariette Paris-Saclay University, INSERM UMR1184: Centre for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicetre, France Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux universitaires Paris-Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Raphael Porcher Assistance Publique Hôpitaux de Paris, Hôtel Dieu hospital, Paris, France Centre d'Epidémiologie Clinique, INSERM U1153, Faculté de Médecine, Université Paris Descartes, Paris, France PubMed articlesGoogle scholar articles
  • on behalf of the NECESSITY WP5 - STAR development working group
    Google scholar articles
  1. Correspondence to Dr Raphaele Seror, Rheumatology, Hopital Bicetre, Le Kremlin-Bicetre 94270, France; raphaele.seror{at}aphp.fr
View Full Text

Citation

Seror R, Baron G, Camus M on behalf of the NECESSITY WP5 - STAR development working group, et al
Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome
Annals of the Rheumatic Diseases 2022;81:979-989.

Publication history

  • Received December 23, 2021
  • Accepted March 9, 2022
  • First published April 7, 2022.
Online issue publication 
October 18, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.